Skip to main content

Townsend Richard Nolan's Form 4 filing

Lexeo Therapeutics, Inc. (LXEO) · filed Jul 12, 2024

Accession no.
0001415889-24-019526
Filed
Jul 12, 2024
Trade date
Jul 10-11, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $923.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Townsend Richard NolanCIK 0001995218Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 10, 2024Common StockMOption exerciseAcquired+5,000$2.33+$11,650175,695Direct
Jul 10, 2024Common StockSSaleDisposed−23,622$16.45−$388,581.9152,073Direct
Jul 10, 2024Common StockSSaleDisposed−3,347$16.85−$56,396.95148,726Direct
Jul 11, 2024Common StockSSaleDisposed−27,931$17.06−$476,502.86120,795Direct
Jul 11, 2024Common StockSSaleDisposed−100$19.06−$1,906120,695Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 10, 2024Common StockMOption exerciseDisposed−5,000$0.00$0138,655Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)